TORAY INDUSTRIES, INC.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Public
- Established
- 1926-04-16
- Employees
- 48.1K
- Market Cap
- -
- Website
- http://www.toray.co.jp
Efficacy and Safety of TRK-700 in Patient With Post-Herpetic Neuralgia
- First Posted Date
- 2016-03-08
- Last Posted Date
- 2017-10-25
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 184
- Registration Number
- NCT02701374
- Locations
- 🇯🇵
Tokyo, Tokyo, Japan
TRK-100STP PhaseII Clinical Study -Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
- First Posted Date
- 2015-06-24
- Last Posted Date
- 2015-06-29
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 113
- Registration Number
- NCT02480751
Efficacy and Safety of MT-9938 for Treatment of Uremic Pruritus in Subjects With End-stage Renal Disease Receiving Hemodialysis
Phase 2
Terminated
- Conditions
- Uremic Pruritus
- Interventions
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 45
- Registration Number
- NCT01660243
A Pharmacokinetic Study of TRK-100STP in Japanese Patients With Renal Impairment
- First Posted Date
- 2011-09-29
- Last Posted Date
- 2014-03-04
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 24
- Registration Number
- NCT01443429
- Locations
- 🇯🇵
Japan, Japan, Japan
A Study of TRK-170 for the Treatment of Crohn's Disease
- First Posted Date
- 2011-05-02
- Last Posted Date
- 2014-06-12
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 123
- Registration Number
- NCT01345799
- Locations
- 🇧🇪
Belgium, Belgium, Belgium
🇧🇬Bulgaria, Bulgaria, Bulgaria
🇨🇿Czech Republic, Czech Republic, Czech Republic
TRK-100STP Clinical Study - Chronic Renal Failure (Primary Glomerular Disease/Nephrosclerosis)
Phase 2
Completed
- Conditions
- Chronic Renal FailureGlomerular DiseaseNephrosclerosis
- Interventions
- Drug: PlaceboDrug: TRK-100STP high doseDrug: TRK-100STP low dose
- First Posted Date
- 2010-03-19
- Last Posted Date
- 2015-02-04
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 892
- Registration Number
- NCT01090037
Phase II Study of TRK-820 Soft Capsules - Intractable Pruritus in Patients With Chronic Liver Disease -
Phase 2
Completed
- Conditions
- Pruritus With Chronic Liver Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-03-19
- Last Posted Date
- 2010-02-01
- Lead Sponsor
- Toray Industries, Inc
- Target Recruit Count
- 120
- Registration Number
- NCT00638495
- Locations
- 🇯🇵
Toray Industries, Inc, Urayasu, Chiba, Japan